Extracellular vesicles (EVs) are membrane-derived particles surrounded by a (phospho)lipid
bilayer that are released by cells in the human body. In addition to direct cell-to-cell contact …

Polymeric particles have recently been used to modulate the behavior of immune cells in the
treatment of various inflammatory conditions. However, there is little understanding of how …

Acute inflammation is essential for initiating and coordinating the body’s response to injuries
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …

Particle shape is becoming increasingly recognized as an important parameter for the
development of vascular-targeted carriers (VTCs) for disease treatment and diagnosis. However, …

Although nano- and microparticle therapeutics have been studied for a range of drug delivery
applications, the presence of these particles in blood flow may have considerable and …

Targeting of drug carriers to the vascular wall is of interest for localized delivery of therapeutics
in many human diseases. Nanometer-sized spherical particles are widely proposed for …

Our nationwide network of BME women faculty collectively argue that racial funding disparity
by the National Institutes of Health (NIH) remains the most insidious barrier to success of …

Glioblastoma (GBM) is one of the most aggressive and lethal solid tumors in human. While
efficacious therapeutics, such as emerging chimeric antigen receptor (CAR)-T cells and …

Extracellular vesicles (EVs) carry diverse bioactive components including nucleic acids,
proteins, lipids and metabolites that play versatile roles in intercellular and interorgan …

Many variants of vascular-targeted carriers (VTCs) have been investigated for therapeutic
intervention in several human diseases. However, in order to optimize the functionality of VTC …